Browse Category

Analyst Forecasts News 14 December 2025 - 15 December 2025

Milestone Pharmaceuticals (MIST) Stock: FDA Approval of CARDAMYST, Launch Timeline, and Analyst Forecasts (Dec. 15, 2025)

Milestone Pharmaceuticals (MIST) Stock: FDA Approval of CARDAMYST, Launch Timeline, and Analyst Forecasts (Dec. 15, 2025)

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) entered a new phase in its corporate life this month: from clinical-stage story stock to a company with an FDA-approved, commercially launchable cardiovascular product. The catalyst is CARDAMYST™ (etripamil) nasal spray, now approved in the
British American Tobacco Stock News (BATS.L / BTI) on Dec. 15, 2025: Buyback Update, Dividend Dates, 2026 Forecast and Analyst Targets

British American Tobacco Stock News (BATS.L / BTI) on Dec. 15, 2025: Buyback Update, Dividend Dates, 2026 Forecast and Analyst Targets

December 15, 2025 British American Tobacco p.l.c. stock is back in focus for income investors and “defensive” equity watchers—because the story is doing that very tobacco-company thing where cash returns look comforting while regulatory and category disruption refuse to be
Uber Stock (NYSE: UBER): News, Earnings Outlook, and Analyst Forecasts to Know Before the US Market Opens on Dec. 15, 2025

Uber Stock (NYSE: UBER): News, Earnings Outlook, and Analyst Forecasts to Know Before the US Market Opens on Dec. 15, 2025

Uber Technologies, Inc. (NYSE: UBER) heads into Monday’s session (Dec. 15, 2025) with investors weighing a sharp focus on autonomy (robotaxis and robotics), international delivery expansion, and a steady drumbeat of regulatory and legal headlines—all against a backdrop of strong
1 28 29 30 31 32 43
Go toTop